BOSTON – A combination of two drugs – one of them an immunotherapy agent – could become a new standard, first-line treatment for patients with metastatic kidney cancer, says an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial. Patients who received the immunotherapy drug avelumab plus axitinib, a targeted agent,...
Tag: <span>Drug Combination for Cancer</span>
Post
A New Treatment Destroyed Breast Cancer Tumors in 11 Days Without Chemo
Drug Combination A new clinical trial demonstrated positive effects caused by the drug combination lapatinib and trastuzumab against HER2 positive breast cancer in a treatment period of just 11 days. Led by researchers at the Institute of Cancer Research, London, the University of Manchester, and University Hospital of South Manchester, the study comprised 257 women with HER2 positive breast cancer who...